Evaluating the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of GEO-D02 DNA and MVA/HIV62B With and Without B63521^11 gp120 and IHV01 gp120 Env Proteins in Healthy, HIV-uninfected Adult Participants

NCT04041674 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Stopped Protocol undergoing additional revisions.

Conditions

HIV Infections

Interventions

BIOLOGICAL: GEO-D02 DNA
BIOLOGICAL: MVA/HIV62B Vaccine
BIOLOGICAL: B63521^11 gp120
BIOLOGICAL: IHV01 Protein
BIOLOGICAL: Protein Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]